Global Information
회사소개 | 문의 | 비교리스트

세계의 체외진단 시장 : 컴포넌트별, 기술별, 최종사용자별, 애플리케이션별 예측(-2026년) - COVID-19의 누적적 영향

In-Vitro Diagnostics Market Research Report by Component, Technology, End User, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2022년 06월 상품코드 989825
페이지 정보 영문 210 Pages 배송안내 1-2일 (영업일 기준)
가격
US $ 3,949 ₩ 5,187,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 6,501,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 7,814,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 10,441,000 PDF (Site License) + Excel
US $ 9,949 ₩ 13,069,000 PDF (Enterprise User License) + Excel


세계의 체외진단 시장 : 컴포넌트별, 기술별, 최종사용자별, 애플리케이션별 예측(-2026년) - COVID-19의 누적적 영향 In-Vitro Diagnostics Market Research Report by Component, Technology, End User, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
발행일 : 2022년 06월 페이지 정보 : 영문 210 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 체외진단 시장 규모는 2020년 562억 6,000만 달러에서 2021년에는 596억 2,000만 달러에 달하고, 6.31%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 2026년에는 812억 5,000만 달러에 달할 전망입니다.

세계의 체외진단(In Vitro Diagnostics) 시장에 대해 조사했으며, 시장의 기회 및 과제, 성장 및 억제요인, COVID-19의 영향, 컴포넌트·기술·최종사용자·애플리케이션·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 커버리지
  • 조사 기간
  • 통화와 가격
  • 언어
  • 제약 사항
  • 이해관계자

제2장 조사 방법

  • 조사 프로세스
    • 정의 : 조사 목적
    • 결정 : 조사 설계
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 해석
    • 책정 : 데이터 검증
    • 공개 : 조사 리포트
    • 반복 : 리포트 업데이트
  • 조사 시행
    • 개시 : 조사 프로세스
    • 계획 : 조사 계획을 작성
    • 시행 : 조사를 시행
    • 검증 : 발견과 분석
    • 출판물 : 조사보고
  • 조사 성과

제3장 개요

  • 서론
  • 시장 전망
  • 컴포넌트별 시장 전망
  • 기술별 시장 전망
  • 애플리케이션별 시장 전망
  • 최종사용자별 시장 전망
  • 지역별 시장 전망
  • 경쟁사 전망

제4장 시장 개요

  • 서론
  • COVID-19의 누적적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장요인
    • 억제요인
    • 시장 기회
    • 과제
  • Porter의 산업 분석

제6장 컴포넌트별 시장

  • 서론
  • 데이터 관리 소프트웨어
  • 기구
  • 시약과 키트
  • 서비스

제7장 기술별 시장

  • 서론
  • 임상화학
    • 기본적인 대사 패널
    • 전해질 패널
    • 지질 프로파일
    • 간패널
    • 신장 프로파일
    • 특수화학 시험
    • 갑상선 기능 패널
  • 응고와 지혈
  • 혈액학
  • 면역화학
    • ELISA(Enzyme-Linked Immunosorbent Assay)
    • Enzyme-Linked Immunospot Assays
    • Radioimmunoassay
    • 신속 검사
    • 웨스턴 블로팅
  • 미생물학
  • 분자진단
    • DNA 시퀀싱과 차세대 시퀀싱
    • 하이브리다이제이션
    • 등온 핵산증폭기술
    • 마이크로어레이
    • 중합효소 연쇄 반응
  • 요검사

제8장 최종사용자별 시장

  • 서론
  • 병원 및 케어 프로바이더
  • 연구소
  • 환자 자가진단

제9장 애플리케이션별 시장

  • 서론
  • 자가면역질환
  • 심장병학
  • 당뇨병
  • 약물 검사
  • HIV/에이즈
  • 감염증
  • 신장학
  • 종양학

제10장 아메리카 시장

  • 서론
  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제11장 아시아태평양 시장

  • 서론
  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제12장 유럽, 중동·아프리카 시장

  • 서론
  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트
  • 영국

제13장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사 SWOT 분석
  • 경쟁 시나리오
    • 합병과 인수
    • 합의, 협업 및 파트너십
    • 신제품 발매와 강화
    • 투자와 자금조달
    • 평가, 인지, 확대

제14장 기업 개요

  • Biomerieux Sa
  • Danaher Corporation
  • Diasorin
  • Johnson & Johnson
  • Ortho Clinical Diagnostics
  • Qiagen
  • Roche Diagnostics
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific

제15장 부록

  • 디스커션 가이드
KSA 21.03.04

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET: DYNAMICS
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2021 VS 2027 (%)
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2021 VS 2027 (USD BILLION)
  • FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2027
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, 2019-2027 (USD BILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2019-2027 (USD BILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2019-2027 (USD BILLION)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2019-2027 (USD BILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
  • FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD BILLION)
  • FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2027
  • FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2019-2027 (USD BILLION)
  • FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, 2019-2027 (USD BILLION)
  • FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, 2019-2027 (USD BILLION)
  • FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, 2019-2027 (USD BILLION)
  • FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, 2019-2027 (USD BILLION)
  • FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, 2019-2027 (USD BILLION)
  • FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 28. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, 2019-2027 (USD BILLION)
  • FIGURE 29. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, 2019-2027 (USD BILLION)
  • FIGURE 31. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 32. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2019-2027 (USD BILLION)
  • FIGURE 33. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 34. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 35. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 36. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, 2019-2027 (USD BILLION)
  • FIGURE 37. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 38. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, 2019-2027 (USD BILLION)
  • FIGURE 39. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 40. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, 2019-2027 (USD BILLION)
  • FIGURE 41. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 42. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, 2019-2027 (USD BILLION)
  • FIGURE 43. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 44. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, 2019-2027 (USD BILLION)
  • FIGURE 45. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 46. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, 2019-2027 (USD BILLION)
  • FIGURE 47. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 48. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, 2019-2027 (USD BILLION)
  • FIGURE 49. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 50. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2019-2027 (USD BILLION)
  • FIGURE 51. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 52. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, 2019-2027 (USD BILLION)
  • FIGURE 53. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 54. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 55. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 56. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2019-2027 (USD BILLION)
  • FIGURE 57. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 58. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, 2019-2027 (USD BILLION)
  • FIGURE 59. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 60. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, 2019-2027 (USD BILLION)
  • FIGURE 61. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 62. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 63. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 64. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2019-2027 (USD BILLION)
  • FIGURE 65. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 66. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2019-2027 (USD BILLION)
  • FIGURE 67. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 68. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, 2019-2027 (USD BILLION)
  • FIGURE 69. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 70. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
  • FIGURE 71. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
  • FIGURE 72. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2027
  • FIGURE 73. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2019-2027 (USD BILLION)
  • FIGURE 74. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 75. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, 2019-2027 (USD BILLION)
  • FIGURE 76. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 77. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, 2019-2027 (USD BILLION)
  • FIGURE 78. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 79. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
  • FIGURE 80. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
  • FIGURE 81. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2027
  • FIGURE 82. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 83. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 84. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 85. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 86. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, 2019-2027 (USD BILLION)
  • FIGURE 87. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 88. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, 2019-2027 (USD BILLION)
  • FIGURE 89. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 90. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, 2019-2027 (USD BILLION)
  • FIGURE 91. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 92. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 93. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 94. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, 2019-2027 (USD BILLION)
  • FIGURE 95. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 96. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 97. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 98. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 99. ARGENTINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 100. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 101. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 102. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 103. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 104. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 105. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 106. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 107. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 108. INDONESIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 109. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 110. MALAYSIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 111. PHILIPPINES IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 112. SINGAPORE IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 113. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 114. TAIWAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 115. THAILAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 116. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 117. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 118. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 119. ITALY IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 120. NETHERLANDS IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 121. QATAR IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 122. RUSSIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 123. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 124. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 125. SPAIN IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 126. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 127. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 128. GLOBAL IN-VITRO DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 129. GLOBAL IN-VITRO DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2021
  • FIGURE 130. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET: SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2019-2027 (USD BILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 5. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 6. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 7. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 10. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 11. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 12. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 13. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 15. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 16. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 17. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 18. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 20. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 21. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 22. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 23. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 26. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 27. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 28. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 29. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 31. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 32. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 33. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 34. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 35. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 36. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 37. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 38. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 39. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 41. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 42. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 43. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 44. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 45. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 46. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 47. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 48. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 49. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 50. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 51. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 52. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 53. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 55. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 56. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 57. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 58. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 61. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 62. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 63. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 66. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 67. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 68. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 71. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 72. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 73. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 75. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 76. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 77. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 78. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 80. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 81. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 82. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 83. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 85. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 86. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 87. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 88. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 90. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 91. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 92. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 93. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 95. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 96. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 97. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 98. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 101. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 102. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 103. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 105. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 106. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 107. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 108. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 110. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 111. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 112. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 113. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 115. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 116. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 117. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 118. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 120. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 121. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 122. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 123. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 125. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 126. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 127. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 128. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 130. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 131. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 132. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 133. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 135. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 136. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 137. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 138. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 140. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 141. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 142. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 143. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 145. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 146. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 147. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 148. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 150. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 151. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 152. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 153. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 155. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 156. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 157. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 158. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 160. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 161. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 162. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 163. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 164. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 166. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 167. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 168. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 169. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 171. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 172. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 173. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 174. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 176. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 177. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 178. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 179. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 180. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 182. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 183. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 184. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 185. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 187. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 188. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 189. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 190. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 192. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 193. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 194. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 195. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 197. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 198. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 199. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 200. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 202. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 203. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 204. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 205. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 207. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 208. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 209. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 210. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 212. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 213. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 214. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 215. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 217. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 218. ARGENTINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 219. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 220. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 221. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 222. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 223. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 224. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 225. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 226. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 227. INDONESIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 228. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 229. MALAYSIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 230. PHILIPPINES IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 231. SINGAPORE IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 232. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 233. TAIWAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 234. THAILAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 236. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 237. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 238. ITALY IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 239. NETHERLANDS IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 240. QATAR IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 241. RUSSIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 242. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 243. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 244. SPAIN IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 245. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 246. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 247. GLOBAL IN-VITRO DIAGNOSTICS MARKET: SCORES
  • TABLE 248. GLOBAL IN-VITRO DIAGNOSTICS MARKET: BUSINESS STRATEGY
  • TABLE 249. GLOBAL IN-VITRO DIAGNOSTICS MARKET: PRODUCT SATISFACTION
  • TABLE 250. GLOBAL IN-VITRO DIAGNOSTICS MARKET: RANKING
  • TABLE 251. GLOBAL IN-VITRO DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2021
  • TABLE 252. GLOBAL IN-VITRO DIAGNOSTICS MARKET: MERGER & ACQUISITION
  • TABLE 253. GLOBAL IN-VITRO DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 254. GLOBAL IN-VITRO DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 255. GLOBAL IN-VITRO DIAGNOSTICS MARKET: INVESTMENT & FUNDING
  • TABLE 256. GLOBAL IN-VITRO DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 257. GLOBAL IN-VITRO DIAGNOSTICS MARKET: LICENSE & PRICING

The Global In-Vitro Diagnostics Market grew USD 86.54 billion by 2027, at a CAGR of 6.40%.

The Global In-Vitro Diagnostics Market size was estimated at USD 59.62 billion in 2021 and expected to reach USD 63.34 billion in 2022, and is projected to grow at a CAGR 6.40% to reach USD 86.54 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the In-Vitro Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Component, the market was studied across Data Management Software, Instruments, Reagents & Kits, and Services.

Based on Technology, the market was studied across Clinical Chemistry, Coagulation & Hemostasis, Hematology, Immunochemistry, Microbiology, Molecular Diagnostics, and Urinalysis. The Clinical Chemistry is further studied across Basic Metabolic Panel, Electrolyte Panel, Lipid Profile, Liver Panel, Renal Profile, Specialty Chemical Tests, and Thyroid Function Panel. The Immunochemistry is further studied across Enzyme-Linked Immunosorbent Assay, Enzyme-Linked Immunospot Assays, Radioimmunoassay, Rapid Test, and Western Blotting. The Enzyme-Linked Immunosorbent Assay is further studied across Chemiluminescence Immunoassays, Colorimetric Immunoassays, and Fluorescence Immunoassays. The Molecular Diagnostics is further studied across DNA Sequencing & Next-Generation Sequencing, Hybridization, Isothermal Nucleic Acid Amplification Technology, Microarray, and Polymerase Chain Reaction.

Based on End User, the market was studied across Hospitals & Care Providers, Laboratories, and Patient Self-Testing.

Based on Application, the market was studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, HIV/Aids, Infectious Diseases, Nephrology, and Oncology.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for In-Vitro Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the In-Vitro Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global In-Vitro Diagnostics Market, including Biomerieux Sa, Danaher Corporation, Diasorin, Johnson & Johnson, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global In-Vitro Diagnostics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global In-Vitro Diagnostics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In-Vitro Diagnostics Market?
  • 4. What is the competitive strategic window for opportunities in the Global In-Vitro Diagnostics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global In-Vitro Diagnostics Market?
  • 6. What is the market share of the leading vendors in the Global In-Vitro Diagnostics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global In-Vitro Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Geriatric population and prevalence of chronic and infectious diseases in Americas
      • 5.1.1.2. Growing awareness on self-testing and personalized medicine
      • 5.1.1.3. Increasing adoption automated instruments and equipment in laboratories
      • 5.1.1.4. Increasing deployment of Point-of-Care testing facilities
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of condition-specific markers and tests
      • 5.1.3.2. Attractive companion diagnostics
      • 5.1.3.3. Growth opportunities in emerging countries
    • 5.1.4. Challenges
      • 5.1.4.1. Changing the regulatory landscape
      • 5.1.4.2. Operational limitations faced in conducting diagnostic tests
  • 5.2. Cumulative Impact of COVID-19

6. In-Vitro Diagnostics Market, by Component

  • 6.1. Introduction
  • 6.2. Data Management Software
  • 6.3. Instruments
  • 6.4. Reagents & Kits
  • 6.5. Services

7. In-Vitro Diagnostics Market, by Technology

  • 7.1. Introduction
  • 7.2. Clinical Chemistry
    • 7.2.1. Basic Metabolic Panel
    • 7.2.2. Electrolyte Panel
    • 7.2.3. Lipid Profile
    • 7.2.4. Liver Panel
    • 7.2.5. Renal Profile
    • 7.2.6. Specialty Chemical Tests
    • 7.2.7. Thyroid Function Panel
  • 7.3. Coagulation & Hemostasis
  • 7.4. Hematology
  • 7.5. Immunochemistry
    • 7.5.1. Enzyme-Linked Immunosorbent Assay
      • 7.5.1.1. Chemiluminescence Immunoassays
      • 7.5.1.2. Colorimetric Immunoassays
      • 7.5.1.3. Fluorescence Immunoassays
    • 7.5.2. Enzyme-Linked Immunospot Assays
    • 7.5.3. Radioimmunoassay
    • 7.5.4. Rapid Test
    • 7.5.5. Western Blotting
  • 7.6. Microbiology
  • 7.7. Molecular Diagnostics
    • 7.7.1. DNA Sequencing & Next-Generation Sequencing
    • 7.7.2. Hybridization
    • 7.7.3. Isothermal Nucleic Acid Amplification Technology
    • 7.7.4. Microarray
    • 7.7.5. Polymerase Chain Reaction
  • 7.8. Urinalysis

8. In-Vitro Diagnostics Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals & Care Providers
  • 8.3. Laboratories
  • 8.4. Patient Self-Testing

9. In-Vitro Diagnostics Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Diseases
  • 9.3. Cardiology
  • 9.4. Diabetes
  • 9.5. Drug Testing
  • 9.6. HIV/Aids
  • 9.7. Infectious Diseases
  • 9.8. Nephrology
  • 9.9. Oncology

10. Americas In-Vitro Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific In-Vitro Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand

12. Europe, Middle East & Africa In-Vitro Diagnostics Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Biomerieux Sa
  • 14.2. Danaher Corporation
  • 14.3. Diasorin
  • 14.4. Johnson & Johnson
  • 14.5. Ortho Clinical Diagnostics
  • 14.6. Qiagen
  • 14.7. Roche Diagnostics
  • 14.8. Siemens AG
  • 14.9. Sysmex Corporation
  • 14.10. Thermo Fisher Scientific

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
Back to Top
전화 문의
F A Q